Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals
Drug Safety · 2024-11 · 47 (11) · 1061-1074
DOI: 10.1007/s40264-024-01453-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Safety, online erschienen am 11.07.2024. Verfasst von Carlotta Lunghi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy. carlotta.lunghi@unibo.it. Hauptthemen laut MEDLINE: Inappropriate Prescribing, Potentially Inappropriate Medication List, Polypharmacy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Open access funding provided by Alma Mater Studiorum - Università di Bologna within the CRUI-CARE Agreement, Alma Mater Studiorum - Università di Bologna.
Abstract (Originalsprache)
The growing complexity of geriatric pharmacotherapy necessitates effective tools for mitigating the risks associated with polypharmacy. The Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP)/Screening Tool to Alert doctors to Right Treatment (START) criteria have been instrumental in optimizing medication management among older adults. Despite their large adoption for improving the reduction of potentially inappropriate medications (PIM) and patient outcomes, the implementation of STOPP/START criteria faces notable challenges. The extensive number of criteria in the latest version and time constraints in primary care pose practical difficulties, particularly in settings with a high number of older patients. This paper critically evaluates the challenges and evolving implications of applying the third version of the STOPP/START criteria across various clinical settings, focusing on the European healthcare context. Utilizing a "Questions & Answers" format, it examines the criteria's implementation and discusses relevant suitability and potential adaptations to address the diverse needs of different clinical environments. By emphasizing these aspects, this paper aims to contribute to the ongoing discourse on enhancing medication safety and efficacy in the geriatric population, and to promote more person-centred care in an aging society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy. carlotta.lunghi@unibo.it.
- Population Health and Optimal Health Practices Research Unit, CHU de Québec-Université Laval Research Centre, Quebec, Quebec, Canada. carlotta.lunghi@unibo.it.
- Department of Medical and Surgical Sciences, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy.
- Department of Medical Biotechnology and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milan, Milan, Italy.
- Department of Gerontology, Neuroscience and Orthopedics, Sacred Heart Catholic University, Rome, Italy.
Förderung
- Open access funding provided by Alma Mater Studiorum - Università di Bologna within the CRUI-CARE Agreement
- Alma Mater Studiorum - Università di Bologna
Zitieren
APA
Lunghi, C., Domenicali, M., Vertullo, S., Raschi, E., De Ponti, F., Onder, G., & Poluzzi, E. (2024). Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals. Drug Safety, 47(11), 1061-1074. https://doi.org/10.1007/s40264-024-01453-1
Vancouver
Lunghi C, Domenicali M, Vertullo S, Raschi E, De Ponti F, Onder G, et al. Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals. Drug Safety. 2024;47(11):1061-1074. doi:10.1007/s40264-024-01453-1
BibTeX
@article{Lunghi2024,
author = {Lunghi, Carlotta and Domenicali, Marco and Vertullo, Stefano and Raschi, Emanuel and De Ponti, Fabrizio and Onder, Graziano and Poluzzi, Elisabetta},
title = {Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals},
journal = {Drug Safety},
year = {2024},
volume = {47},
number = {11},
pages = {1061--1074},
doi = {10.1007/s40264-024-01453-1}
}
EUVIMED